• メニュー
  • TOP
  • 入会案内
  • 各種変更届
  • 概要
  • 会告
  • 学会誌
  • 乳がんコンテンツ
  • リンク
乳房超音波講習会
マンモグラフィ講習会

学会誌バックナンバー一覧

  • 第11巻第2号の目次へ
  • 目次へ戻る
  • 学会誌一覧
  • 学会誌バックナンバーへ

Original Article―――――――――――――――――――――――――――――――――――――― 原  著

Characteristics of Interval Breast Cancer

Daisuke Ota1)

Tadahraru Matsunaga1)

Takeharu Misaka1)

Katsumasa Hosokawa1)

Masahiko Fujii2)

Mikihiro Kusama3)

Hiroshi Kaise3)

Shun Nakayama3)

Tatsuya Aoki3)

Yasuhisa Koyanagi3)

Yasuhiko Hakamada4)

Masaaki Arima4)

Breast Department, Tokyo Metropolitan Cancer Detection Center1)
Department of Pathology, Kyorin University School of Health Science2)
Third Department of Surgery, Tokyo Medical College3)
Department of Surgery, Tokyo Metropolitan Otsuka Hospital4)


  In addition to palpation, screening of breast cancer is performed by mammography and ultrasonography at our facility. We studied women who were found to have single, unilateral breast cancers between1996 and 2000. They were classified into three groups 'interval breast cancer', 'breast cancer diagnosed by periodic screening', and 'breast cancer diagnosed in the outpatient department'−and studied clinicopathologically. There were no significant differences in age, body mass index, menopausal status, or age at first parturition among the three groups. The proportion of nonpalpable breast cancers in the 'breast cancer diagnosed by periodic screening' group was significantly(p <0.01)higher than in other groups. There was significantly(p <0.05)more women with 'familial history in the interval breast cancer' group than in the other groups. Symptoms appeared sooner in women who had interval breast cancer without a familial history. With regard to pathological findings, scirrhous carcinoma appeared in a signicantly(p <.01)greater proportion of women in the 'breast cancer diagnosed by periodic screening' group than in the other groups. The mean of distance of tumor in the 'breast cancer diagnosed by periodic screening' group was significantly(p=0.05)smaller than in the 'breast cancer diagnosed in the outpatient clinic' group(p=0.05). In future, screening for breast cancer needs to focus on three issues : more detailed investigation of patients in whom breast cancer is overlooked, modality−preferably ultrasonography, and recommendation for annual screening.


Key words : interval breast cancer, screening for breast cancer

  • 第11巻第2号の目次へ
  • 目次へ戻る
  • 学会誌一覧
  • 学会誌バックナンバーへ